219 related articles for article (PubMed ID: 35554919)
21. Application of Biosafety Principles in Laboratory Analysis of Clinical Samples from Patients with COVID-19.
Hussain Gardezi SA; Ikram A
J Pak Med Assoc; 2020 May; 70(Suppl 3)(5):S48-S51. PubMed ID: 32515375
[TBL] [Abstract][Full Text] [Related]
22. Selection and application of biological safety cabinets in diagnostic and research laboratories with special emphasis on COVID-19.
Pawar SD; Khare AB; Keng SS; Kode SS; Tare DS; Singh DK; More RL; Mullick J
Rev Sci Instrum; 2021 Aug; 92(8):081401. PubMed ID: 34470433
[TBL] [Abstract][Full Text] [Related]
23. Laboratory biosafety measures involving SARS-CoV-2 and the classification as a Risk Group 3 biological agent.
Kaufer AM; Theis T; Lau KA; Gray JL; Rawlinson WD
Pathology; 2020 Dec; 52(7):790-795. PubMed ID: 33070960
[TBL] [Abstract][Full Text] [Related]
24. Harmonization of Biosafety and Biosecurity Standards for High-Containment Facilities in Low- and Middle-Income Countries: An Approach From the Perspective of Occupational Safety and Health.
Maehira Y; Spencer RC
Front Public Health; 2019; 7():249. PubMed ID: 31572701
[TBL] [Abstract][Full Text] [Related]
25. The Culture of Biosafety, Biosecurity, and Responsible Conduct in the Life Sciences: A Comprehensive Literature Review.
Perkins D; Danskin K; Rowe AE; Livinski AA
Appl Biosaf; 2019 Mar; 24(1):34-45. PubMed ID: 36034634
[TBL] [Abstract][Full Text] [Related]
26. Operational considerations and challenges of biochemistry laboratories during the COVID-19 outbreak: an IFCC global survey.
Loh TP; Horvath AR; Wang CB; Koch D; Adeli K; Mancini N; Ferrari M; Hawkins R; Sethi S; Lippi G;
Clin Chem Lab Med; 2020 Aug; 58(9):1441-1449. PubMed ID: 32549122
[TBL] [Abstract][Full Text] [Related]
27. Significance of High-Containment Biological Laboratories Performing Work During the COVID-19 Pandemic: Biosafety Level-3 and -4 Labs.
Yeh KB; Tabynov K; Parekh FK; Mombo I; Parker K; Tabynov K; Bradrick SS; Tseng AS; Yang JR; Gardiner L; Olinger G; Setser B
Front Bioeng Biotechnol; 2021; 9():720315. PubMed ID: 34485259
[TBL] [Abstract][Full Text] [Related]
28. Implementation of a personnel reliability program as a facilitator of biosafety and biosecurity culture in BSL-3 and BSL-4 laboratories.
Higgins JJ; Weaver P; Fitch JP; Johnson B; Pearl RM
Biosecur Bioterror; 2013 Jun; 11(2):130-7. PubMed ID: 23745523
[TBL] [Abstract][Full Text] [Related]
29. Challenges in Implementing a Biorisk Management Program at Universitas Indonesia: A Checklist Tool for Biorisk Management.
Naroeni A; Bachtiar EW; Ibrahim F; Bela B; Kusminanti Y; Pujiriani I; Lestari F
Health Secur; 2016; 14(6):375-381. PubMed ID: 27830940
[TBL] [Abstract][Full Text] [Related]
30. A Mentorship Program to Develop Biorisk Manuals for Laboratories in Pakistan.
Sarwar S; Moreno MMN; Chaudhri M; Aamir UB; Ikram A
Appl Biosaf; 2022 Dec; 27(4):219-224. PubMed ID: 36761992
[TBL] [Abstract][Full Text] [Related]
31. Challenges in the establishment of a biosafety testing laboratory for COVID-19 in Bangladesh.
Islam SRU; Akther T; Sultana S; Deb P; Ghosh AK; Nasif MAO; Bhuiyan AH; Jahan M; Nessa A; Munshi SU; Tabassum S
J Infect Dev Ctries; 2021 Dec; 15(12):1833-1837. PubMed ID: 35044940
[TBL] [Abstract][Full Text] [Related]
32. Development of a Single-Cycle Infectious SARS-CoV-2 Virus Replicon Particle System for Use in Biosafety Level 2 Laboratories.
Malicoat J; Manivasagam S; Zuñiga S; Sola I; McCabe D; Rong L; Perlman S; Enjuanes L; Manicassamy B
J Virol; 2022 Feb; 96(3):e0183721. PubMed ID: 34851142
[TBL] [Abstract][Full Text] [Related]
33. Establishing a national biological laboratory safety and security monitoring program.
Blaine JW
Biosecur Bioterror; 2012 Dec; 10(4):396-400. PubMed ID: 23210833
[TBL] [Abstract][Full Text] [Related]
34. Meta-analysis to explain unknown causes of the origins of SARS-COV-2.
Coccia M
Environ Res; 2022 Aug; 211():113062. PubMed ID: 35259407
[TBL] [Abstract][Full Text] [Related]
35. Systematic approach towards establishing a National Inventory of Dangerous Pathogens.
Vennis IM; Bleijs DA; Brizee S; Van Den Berg HHJL; Kampert E; Rutjes SA; Van Passel MWJ
Glob Health Action; 2021 Jan; 14(1):1971866. PubMed ID: 34493169
[TBL] [Abstract][Full Text] [Related]
36. The changing world of biocontainment and biosecurity.
Jeggo M
Dev Biol (Basel); 2007; 128():47-51. PubMed ID: 18084927
[TBL] [Abstract][Full Text] [Related]
37. National Laboratory Planning: Developing Sustainable Biocontainment Laboratories in Limited Resource Areas.
Yeh KB; Adams M; Stamper PD; Dasgupta D; Hewson R; Buck CD; Richards AL; Hay J
Health Secur; 2016; 14(5):323-30. PubMed ID: 27559843
[TBL] [Abstract][Full Text] [Related]
38. Mobile High-Containment Biological Laboratories Deployment: Opportunities and Challenges in Expeditionary Deployments to Outbreak Response.
Rao V; Bordelon E
Appl Biosaf; 2019 Mar; 24(1):20-29. PubMed ID: 36034633
[TBL] [Abstract][Full Text] [Related]
39. Procedures for Flow Cytometry-Based Sorting of Unfixed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Cells and Other Infectious Agents.
Reifel KM; Swan BK; Jellison ER; Ambrozak D; Baijer J; Nguyen R; Monard S; Lyon G; Fontes B; Perfetto SP
Cytometry A; 2020 Jul; 97(7):674-680. PubMed ID: 32488957
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
